Merck

Who will win the Opdivo-Keytruda coverage clash?
Medical Marketing and Media
Tue, 12/30/14 - 10:29 am
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
The Most Important New Drug Of 2014
Forbes
Tue, 12/30/14 - 10:15 am
Ketruda
Merck
Opdivo
Bristol-Myers Squibb
5 Top Pharmaceutical Stock Picks for 2015
24/7 Wall St
Mon, 12/29/14 - 10:52 am
Merck
Bristol-Myers Squibb
Eli Lilly
Shire
Flamel
Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When
Seeking Alpha
Fri, 12/26/14 - 10:18 pm
Merck
diabetes
omarigliptin
MK-1293
ertugliflozin
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
immuno-oncology
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Amgen
AstraZeneca
Year in review: The biggest stories in biotech in 2014
Bizjournals.com
Fri, 12/26/14 - 09:51 am
biotech
Merck
M&A
Cubist Pharmaceuticals
Idenix
Covidien
Medtronic
Gilead Sciences
Shire
AbbVie
drug pricing
NewLink, GSK get U.S. funding for faster development of Ebola vaccines
Yahoo/Reuters
Wed, 12/24/14 - 08:51 am
NewLink Genetics
GSK
ebola virus
vaccines
Merck
GSK shingles vax shaping up to compete with Merck's
Medical Marketing and Media
Tue, 12/23/14 - 10:39 am
GSK
Merck
vaccines
shingles
HZ/su
Zostavax
Merck Finally Gets Some Good News on Cubist
WSJ Online
Mon, 12/22/14 - 01:17 pm
Merck
Cubist
FDA
M&A
Zerbaxa
Merck Begins Tender Offer to Acquire Cubist
Yahoo
Fri, 12/19/14 - 08:18 am
Merck
Cubist
M&A
Merck beefs up its cancer drug pipeline in $375M OncoEthix buyout
Fierce Biotech
Thu, 12/18/14 - 10:04 am
Merck
OncoEthix
M&A
cancer
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Biogen Idec
Bluebird Bio
Arrowhead Research
Vertex Pharmaceuticals
Cempra
CTI BioPharma
Gilead Sciences
Merck
Bristol-Myers Squibb
Sarepta Therapeutics
Neurocrine Biosciences
Merck looks for $8B bridge loan for Cubist acquisition
Reuters
Mon, 12/15/14 - 09:24 pm
Merck
M&A
Cubist Pharma
Can Newly Approved Gardasil 9 Boost Merck & Co.’s (MRK) Vaccine Business?
Bidness Etc.
Thu, 12/11/14 - 10:15 am
Merck
vaccines
Gardasil
Gardasil 9
HPV
NewLink Ebola Shot Test Halted in Geneva on Side Effect
Bloomberg
Thu, 12/11/14 - 10:06 am
NewLink
ebola virus
clinical trials
side effects
Merck
vaccines
One shot or two? Many questions unresolved in Ebola vaccine race
Yahoo/Reuters
Thu, 12/11/14 - 08:38 am
ebola virus
vaccines
GSK
NewLink Genetics
JNJ
Merck
FDA clears new version of Gardasil
Seeking Alpha
Wed, 12/10/14 - 05:52 pm
FDA
Gardasil
HPV
vaccines
Merck
Merck drug shrank tumors in some breast cancer patients in trial
Marketwatch
Wed, 12/10/14 - 09:44 am
Merck
Keytruda
triple-negative breast cancer
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
WSJ Online
Wed, 12/10/14 - 08:13 am
Merck
Cubist Pharma
M&A
Cubicin
antibiotics

Pages